{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Dyrk1A", "catechins", "metabolic syndrome", "trisomy 21"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35631180", "DateCompleted": {"Year": "2022", "Month": "05", "Day": "31"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "12"}], "Language": ["eng"], "ELocationID": ["2039", "10.3390/nu14102039"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "14", "Issue": "10", "PubDate": {"Year": "2022", "Month": "May", "Day": "12"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Catechins as a Potential Dietary Supplementation in Prevention of Comorbidities Linked with Down Syndrome.", "Abstract": {"AbstractText": ["Plant-derived polyphenols flavonoids are increasingly being recognized for their medicinal potential. These bioactive compounds derived from plants are gaining more interest in ameliorating adverse health risks because of their low toxicity and few side effects. Among them, therapeutic approaches demonstrated the efficacy of catechins, a major group of flavonoids, in reverting several aspects of Down syndrome, the most common genomic disorder that causes intellectual disability. Down syndrome is characterized by increased incidence of developing Alzheimer's disease, obesity, and subsequent metabolic disorders. In this focused review, we examine the main effects of catechins on comorbidities linked with Down syndrome. We also provide evidence of catechin effects on DYRK1A, a dosage-sensitive gene encoding a protein kinase involved in brain defects and metabolic disease associated with Down syndrome."]}, "AuthorList": [{"Identifier": ["0000-0002-2874-2060"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Endocrinology, Department of Medicine, Centre de Recherche du CHUS, Universit\u00e9 de Sherbrooke, Sherbrooke, QC J1K 2R1, Canada."}], "LastName": "Noll", "ForeName": "Christophe", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Biologie Fonctionnelle et Adaptative, UMR 8251 CNRS, Universit\u00e9 Paris Cit\u00e9, F-75013 Paris, France."}], "LastName": "Kandiah", "ForeName": "Janany", "Initials": "J"}, {"Identifier": ["0000-0002-8973-0477"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Biologie Fonctionnelle et Adaptative, INSERM CNRS, Universit\u00e9 Paris Cit\u00e9, F-75013 Paris, France."}], "LastName": "Moroy", "ForeName": "Gautier", "Initials": "G"}, {"Identifier": ["0000-0003-3188-2264"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Biologie Fonctionnelle et Adaptative, UMR 8251 CNRS, Universit\u00e9 Paris Cit\u00e9, F-75013 Paris, France."}], "LastName": "Gu", "ForeName": "Yuchen", "Initials": "Y"}, {"Identifier": ["0000-0003-1767-0572"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, UMR 8601 CNRS, Universit\u00e9 Paris Cit\u00e9, F-75006 Paris, France."}], "LastName": "Dairou", "ForeName": "Julien", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit\u00e9 de Biologie Fonctionnelle et Adaptative, UMR 8251 CNRS, Universit\u00e9 Paris Cit\u00e9, F-75013 Paris, France."}], "LastName": "Janel", "ForeName": "Nathalie", "Initials": "N"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "8R1V1STN48", "NameOfSubstance": "Catechin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Catechin"}, {"QualifierName": [], "DescriptorName": "Comorbidity"}, {"QualifierName": [], "DescriptorName": "Dietary Supplements"}, {"QualifierName": [], "DescriptorName": "Down Syndrome"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Polyphenols"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Manach C., Scalbert A., Morand C., R\u00e9m\u00e9sy C., Jim\u00e9nez L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004;79:727\u2013747. doi: 10.1093/ajcn/79.5.727.", "ArticleIdList": ["10.1093/ajcn/79.5.727", "15113710"]}, {"Citation": "Spencer J.P. Flavonoids: Modulators of brain function? Br. J. Nutr. 2008;1:ES60\u2013ES77. doi: 10.1017/S0007114508965776.", "ArticleIdList": ["10.1017/S0007114508965776", "18503736"]}, {"Citation": "Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005;81:230S\u2013242S. doi: 10.1093/ajcn/81.1.230S.", "ArticleIdList": ["10.1093/ajcn/81.1.230S", "15640486"]}, {"Citation": "Del Rio D., Costa L.G., Lean M.E.J., Crozier A. Polyphenols and health: What compounds are involved? Nutr. Metab. Cardiovasc. Dis. 2010;20:1\u20136. doi: 10.1016/j.numecd.2009.05.015.", "ArticleIdList": ["10.1016/j.numecd.2009.05.015", "19713090"]}, {"Citation": "Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 1983;32:1141\u20131148. doi: 10.1016/0006-2952(83)90262-9.", "ArticleIdList": ["10.1016/0006-2952(83)90262-9", "6342623"]}, {"Citation": "Mastroiacovo D., Kwik-Uribe C., Grassi D., Necozione S., Raffaele A., Pistacchio L., Righetti R., Bocale R., Lechiara M.C., Marini C. Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: The Cocoa, Cognition, and Aging (CoCoA) Study\u2014A randomized controlled trial. Am. J. Clin. Nutr. 2015;101:538\u2013548. doi: 10.3945/ajcn.114.092189.", "ArticleIdList": ["10.3945/ajcn.114.092189", "PMC4340060", "25733639"]}, {"Citation": "Tufarelli V., Casalino E., D\u2019Alessandro A.G., Laudadio V. Dietary Phenolic Compounds: Biochemistry, Metabolism and Significance in Animal and Human Health. Curr. Drug Metab. 2017;18:905\u2013913. doi: 10.2174/1389200218666170925124004.", "ArticleIdList": ["10.2174/1389200218666170925124004", "28952431"]}, {"Citation": "Del Bo C., Bernardi S., Marino M., Porrini M., Tucci M., Guglielmetti S., Cherubini A., Carrieri B., Kirkup B., Kroon P., et al. Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern? Nutrients. 2019;11:1355.", "ArticleIdList": ["PMC6627994", "31208133"]}, {"Citation": "Bakoyiannis I., Daskalopoulou A., Pergialiotis V., Perrea D. Phytochemicals and cognitive health: Are flavonoids doing the trick? Biomed. Pharmacother. 2019;109:1488\u20131497. doi: 10.1016/j.biopha.2018.10.086.", "ArticleIdList": ["10.1016/j.biopha.2018.10.086", "30551400"]}, {"Citation": "Bergland A.K., Soennesyn H., Dalen I., Rodriguez-Mateos A., Berge R.K., Giil L.M., Rajendran L., Siow R., Tassotti M., Aarsland D., et al. Effects of Anthocyanin Supplementation on Serum Lipids, Glucose, Markers of Inflammation and Cognition in Adults with Increased Risk of Dementia\u2014A Pilot Study. Front. Genet. 2019;10:536. doi: 10.3389/fgene.2019.00536.", "ArticleIdList": ["10.3389/fgene.2019.00536", "PMC6581024", "31244884"]}, {"Citation": "Chai S.C., Jerusik J., Davis K., Wright R.S., Zhang Z. Effect of Montmorency tart cherry juice on cognitive performance in older adults: A randomized controlled trial. Food Funct. 2019;10:4423\u20134431. doi: 10.1039/C9FO00913B.", "ArticleIdList": ["10.1039/C9FO00913B", "31287117"]}, {"Citation": "Williams R.J., Spencer J.P.E. Flavonoids, cognition, and dementia: Actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 2012;52:35\u201345. doi: 10.1016/j.freeradbiomed.2011.09.010.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.09.010", "21982844"]}, {"Citation": "Jin Y., Jin C.H., Ho R.K. Separation of catechin compounds from different teas. Biotechnol. J. 2006;1:209\u2013213. doi: 10.1002/biot.200500019.", "ArticleIdList": ["10.1002/biot.200500019", "16892250"]}, {"Citation": "Isemura M. Catechin in human health and disease. Molecules. 2019;24:528. doi: 10.3390/molecules24030528.", "ArticleIdList": ["10.3390/molecules24030528", "PMC6384718", "30717121"]}, {"Citation": "Zhang Y.J., Gan R.Y., Li S., Zhou Y., Li A.N., Xu D.P., Li H.B. Antioxidant Phytochemicals for the Prevention and Treatment of Chronic Diseases. Molecules. 2015;20:21138\u201321156. doi: 10.3390/molecules201219753.", "ArticleIdList": ["10.3390/molecules201219753", "PMC6331972", "26633317"]}, {"Citation": "Fraga C.G., Galleano M., Verstraeten S.V., Oteiza P.I. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol. Asp. Med. 2010;31:435\u2013445. doi: 10.1016/j.mam.2010.09.006.", "ArticleIdList": ["10.1016/j.mam.2010.09.006", "20854840"]}, {"Citation": "Bors W., Heller W., Michel C., Saran M. Flavonoids as antioxidants: Determination of radical-scavenging efficiencies. Methods Enzymol. 1990;186:343\u2013355.", "ArticleIdList": ["2172711"]}, {"Citation": "Rice-Evans C.A., Miller N.J., Bolwell P.G., Bramley P.M., Pridham J.B. The Relative Antioxidant Activities of Plant-Derived Polyphenolic Flavonoids. Free Radic. Res. 1995;22:375\u2013383. doi: 10.3109/10715769509145649.", "ArticleIdList": ["10.3109/10715769509145649", "7633567"]}, {"Citation": "Bernatoniene J., Kopustinskiene D.M. The Role of Catechins in Cellular Responses to Oxidative Stress. Molecules. 2018;23:965. doi: 10.3390/molecules23040965.", "ArticleIdList": ["10.3390/molecules23040965", "PMC6017297", "29677167"]}, {"Citation": "Khan S.G., Katiyar S.K., Agarwal R., Mukhtar H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: Possible role in cancer chemoprevention. Cancer Res. 1992;52:4050\u20134052.", "ArticleIdList": ["1617681"]}, {"Citation": "Grzesik M., Napar\u0142o K., Bartosz G., Sadowska-Bartosz I. Antioxidant properties of catechins: Comparison with other antioxidants. Food Chem. 2018;241:480\u2013492. doi: 10.1016/j.foodchem.2017.08.117.", "ArticleIdList": ["10.1016/j.foodchem.2017.08.117", "28958556"]}, {"Citation": "Kim E., Hwang K., Lee J., Han S., Kim E.M., Park J., Cho J.Y. Skin protective effect of epigallocatechin gallate. Int. J. Mol. Sci. 2018;19:E173. doi: 10.3390/ijms19010173.", "ArticleIdList": ["10.3390/ijms19010173", "PMC5796122", "29316635"]}, {"Citation": "Fraga C.G., Oteiza P.I. Dietary flavonoids: Role of (\u2212)-epicatechin and related procyanidins in cell signaling. Free Radic. Biol. Med. 2011;51:813\u2013823. doi: 10.1016/j.freeradbiomed.2011.06.002.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.06.002", "21699974"]}, {"Citation": "Khan N., Mukhtar H. Teapolyphenolsinpromotionofhumanhealth. Nutrients. 2019;11:39. doi: 10.3390/nu11010039.", "ArticleIdList": ["10.3390/nu11010039", "PMC6356332", "30585192"]}, {"Citation": "Han S.Y., Kim E., Hwang K., Ratan Z.A., Hwang H., Kim E.-M., Kim D., Park J., Cho J.Y. Cytoprotective effect of epigallocatechin gallate (EGCG)-5\u2032-O-\u03b1-glucopyranoside, a novel EGCG derivative. Int. J. Mol. Sci. 2018;19:1466. doi: 10.3390/ijms19051466.", "ArticleIdList": ["10.3390/ijms19051466", "PMC5983637", "29762498"]}, {"Citation": "Biasibetti R., Tramontina A.C., Costa A.P., Dutra M.F., Quincozes-Santos A., Nardin P., Bernardi C.L., Wartchow K.M., Lunardi P.S., Goncalves C.A. Green tea (\u2212) epigallocatechin-3-gallate reverses oxidative stress and reduces acetylcholinesterase activity in a streptozotocin-induced model of dementia. Behav. Brain Res. 2013;236:186\u2013193. doi: 10.1016/j.bbr.2012.08.039.", "ArticleIdList": ["10.1016/j.bbr.2012.08.039", "22964138"]}, {"Citation": "Pereira R.B., Sousa C., Costa A., Andrade P.B., Valent\u00e3o P. Glutathione and the Antioxidant Potential of Binary Mixtures with Flavonoids: Synergisms and Antagonisms. Molecules. 2013;18:8858\u20138872. doi: 10.3390/molecules18088858.", "ArticleIdList": ["10.3390/molecules18088858", "PMC6270187", "23892632"]}, {"Citation": "Br\u00fcckner M., Westphal S., Domschke W., Kucharzik T., L\u00fcgering A. Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. J. Crohns. Colitis. 2012;6:226\u2013235. doi: 10.1016/j.crohns.2011.08.012.", "ArticleIdList": ["10.1016/j.crohns.2011.08.012", "22325177"]}, {"Citation": "Kim C.Y., Lee C., Park G.H., Jang J.H. Neuroprotective Effect of Epigallocatechin-3-gallate against \u03b2-Amyloid-induced Oxidative and Nitrosative Cell Death via Augmentation of Antioxidant Defense Capacity. Arch. Pharm. Res. 2009;32:869\u2013881. doi: 10.1007/s12272-009-1609-z.", "ArticleIdList": ["10.1007/s12272-009-1609-z", "19557365"]}, {"Citation": "Marinovic M.P., Morandi A.C., Otton R. Green tea catechins alone or in combination alter functional parameters of human neutrophils via suppressing the activation of TLR-4/NF\u03baB p65 signal pathway. Toxicol. In Vitro. 2015;29:1766\u20131778. doi: 10.1016/j.tiv.2015.07.014.", "ArticleIdList": ["10.1016/j.tiv.2015.07.014", "26187476"]}, {"Citation": "Nadim M., Auriol D., Lamerant-Faye L.N., Lef\u00e8vre F., Dubanet L., Redziniak G., Kieda C., Grillon C. Improvement of polyphenol properties upon glucosylation in a UV-induced skin cell ageing model. Int. J. Cosmet. Sci. 2014;36:579\u2013587. doi: 10.1111/ics.12159.", "ArticleIdList": ["10.1111/ics.12159", "25196711"]}, {"Citation": "Feng B., Fang Y., Wei S.M. Effect and mechanism of epigallocatechin-3-gallate (EGCG) against the hydrogen peroxide-induced oxidative damage in human dermal fibroblasts. J. Cosmet. Sci. 2013;64:35\u201344.", "ArticleIdList": ["23449129"]}, {"Citation": "Zhong Y., Shahidi F. Lipophilized epigallocatechin gallate (EGCG) derivatives as novel antioxidants. J. Agric. Food Chem. 2011;59:6526\u20136533. doi: 10.1021/jf201050j.", "ArticleIdList": ["10.1021/jf201050j", "21526762"]}, {"Citation": "Saeki K., Hayakawa S., Nakano S., Ito S., Oishi Y., Suzuki Y., Isemura M. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea. Molecules. 2018;23:1295. doi: 10.3390/molecules23061295.", "ArticleIdList": ["10.3390/molecules23061295", "PMC6099932", "29843451"]}, {"Citation": "Liu S.H., Lu T.H., Su C.C., Lay I.S., Lin H.Y., Fang K.M., Ho T.J., Chen K.L., Su Y.C., Chiang W.C., et al. Lotus Leaf (Nelumbo nucifera) and its Active Constituents Prevent Inflammatory Responses in Macrophages via JNK/NF-\u03baB Signaling Pathway. Am. J. Chin. Med. 2014;42:869\u2013889. doi: 10.1142/S0192415X14500554.", "ArticleIdList": ["10.1142/S0192415X14500554", "25004880"]}, {"Citation": "Fan F.Y., Sang L.X., Jiang M. Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease. Molecules. 2017;22:484. doi: 10.3390/molecules22030484.", "ArticleIdList": ["10.3390/molecules22030484", "PMC6155401", "28335502"]}, {"Citation": "Braicu C., Ladomery M.R., Chedea V.S., Irimie A., Berindan-Neagoe I. The relationship between the structure and biological actions of green tea catechins. Food Chem. 2013;141:3282\u20133289. doi: 10.1016/j.foodchem.2013.05.122.", "ArticleIdList": ["10.1016/j.foodchem.2013.05.122", "23871088"]}, {"Citation": "Ohishi T., Goto S., Monira P., Isemura M., Nakamura Y. Anti-inflammatory Action of Green Tea. Antiinflamm Antiallergy Agents Med Chem. 2016;15:74\u201390. doi: 10.2174/1871523015666160915154443.", "ArticleIdList": ["10.2174/1871523015666160915154443", "27634207"]}, {"Citation": "Chiou Y.S., Huang Q., Ho C.T., Wang Y.J., Pan M.H. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (\u2013)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia. Free Radic. Biol. Med. 2016;94:1\u201316. doi: 10.1016/j.freeradbiomed.2016.02.010.", "ArticleIdList": ["10.1016/j.freeradbiomed.2016.02.010", "26878775"]}, {"Citation": "Feng W.Y. Metabolism of Green Tea Catechins: An Overview. Curr. Drug Metab. 2006;7:755\u2013809. doi: 10.2174/138920006778520552.", "ArticleIdList": ["10.2174/138920006778520552", "17073579"]}, {"Citation": "Rothwell J.A., Madrid-Gambin F., Garcia-Aby M., Andres-Lacueva C., Logue C., Gallagher A.M., Mack C., Kulling S.E., Gao Q., Pratici G., et al. Biomarkers of intake for coffee, tea, and sweetened beverages. Genes Nutr. 2018;13:15. doi: 10.1186/s12263-018-0607-5.", "ArticleIdList": ["10.1186/s12263-018-0607-5", "PMC6030755", "29997698"]}, {"Citation": "Lanzillotta C., Di Domenico F. Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules. Biomolecules. 2021;11:266. doi: 10.3390/biom11020266.", "ArticleIdList": ["10.3390/biom11020266", "PMC7916967", "33670211"]}, {"Citation": "Bull M.J. Down Syndrome. N. Engl. J. Med. 2020;382:2344\u20132352. doi: 10.1056/NEJMra1706537.", "ArticleIdList": ["10.1056/NEJMra1706537", "32521135"]}, {"Citation": "Langdon J., Down H. Observations on an ethnic classification of idiots. Heredity. 1866;21:695\u2013697. doi: 10.1038/hdy.1966.69.", "ArticleIdList": ["10.1038/hdy.1966.69"]}, {"Citation": "Lejeune J., Gautier M., Turpin R. Study of somatic chromosomes from 9 mongoloid children. Comptes Rendus Hebd. Seances l\u2019Acad. Des Sci. 1959;248:1721\u20131722.", "ArticleIdList": ["13639368"]}, {"Citation": "Vranekovi\u0107 J., Bo\u017eovi\u0107 I.B., Grubi\u0107 Z., Wagner J., Pavlini\u0107 D., Dahoun S., Bena F., \u010culi\u0107 V., Brajenovi\u0107-Mili\u0107 B. Down Syndrome: Parental Origin, Recombination, and Maternal Age. Genet. Test. Mol. Biomark. 2012;16:70\u201373. doi: 10.1089/gtmb.2011.0066.", "ArticleIdList": ["10.1089/gtmb.2011.0066", "PMC3265771", "21861707"]}, {"Citation": "Dierssen M. Down syndrome: The brain in trisomic mode. Nat. Rev. Neurosci. 2012;13:844\u2013858. doi: 10.1038/nrn3314.", "ArticleIdList": ["10.1038/nrn3314", "23165261"]}, {"Citation": "Akhtar F., Bokhari S.R.A. StatPearls. StatPearls Publishing; Teasure Island, FL, USA: 2021. Down Syndrome."}, {"Citation": "Kellar D., Craft S. Brain insulin resistance in Alzheimer's disease and related disorders: Mechanisms and therapeutic approaches. Lancet Neurol. 2020;9:758\u2013766. doi: 10.1016/S1474-4422(20)30231-3.", "ArticleIdList": ["10.1016/S1474-4422(20)30231-3", "PMC9661919", "32730766"]}, {"Citation": "Tramutola A., Lanzillotta C., Di Domenico F., Head E., Butterfield D.A., Perluigi M., Barone E. Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome. Neurobiol Dis. 2020;137:104772. doi: 10.1016/j.nbd.2020.104772.", "ArticleIdList": ["10.1016/j.nbd.2020.104772", "31987911"]}, {"Citation": "Sinet P.M., Th\u00e9ophile D., Rahmani Z., Chettouh Z., Blouin J.L., Prieur M., Noel B., Delabar J.M. Mapping of the Down syndrome phenotype on chromosome 21 at the molecular level. Biomed. Pharmacother. 1994;48:247\u2013252. doi: 10.1016/0753-3322(94)90140-6.", "ArticleIdList": ["10.1016/0753-3322(94)90140-6", "7999986"]}, {"Citation": "Lyle R., B\u00e9na F., Gagos S., Gehrig C., Lopez G., Schinzel A., Lespinasse J., Bottani A., Dahoun S., Taine L. Genotype\u2013phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur. J. Hum. Genet. 2009;17:454\u2013466. doi: 10.1038/ejhg.2008.214.", "ArticleIdList": ["10.1038/ejhg.2008.214", "PMC2986205", "19002211"]}, {"Citation": "Olson L.E., Roper R.J., Sengstaken C.L., Peterson E.A., Aquino V., Galdzicki Z., Siarey R., Pletnikov M., Moran T.H., Reeves R.H. Trisomy for the Down syndrome \u00ab critical region \u00bb is necessary but not sufficient for brain phenotypes of trisomic mice. Hum. Mol. Genet. 2007;16:774\u2013782. doi: 10.1093/hmg/ddm022.", "ArticleIdList": ["10.1093/hmg/ddm022", "17339268"]}, {"Citation": "Gupta M., Dhanasekaran A.R., Gardiner K.J. Mouse models of Down syndrome: Gene content and consequences. Mamm. Genome. 2016;27:11\u201312. doi: 10.1007/s00335-016-9661-8.", "ArticleIdList": ["10.1007/s00335-016-9661-8", "PMC5471624", "27538963"]}, {"Citation": "Herault Y., Delabar J.M., Fisher E.M.C., Tybulewicz V.L.J., Yu E., Brault V. Rodent models in Down syndrome research: Impact and future opportunities. Dis. Models Mech. 2017;10:1165\u20131186. doi: 10.1242/dmm.029728.", "ArticleIdList": ["10.1242/dmm.029728", "PMC5665454", "28993310"]}, {"Citation": "Becker W., Joost H.-G. Structural and functional characteristics of dyrk, a novel subfamily of protein kinases with dual specificity. Prog. Nucleic Acid Res. Mol. Biol. 1998;62:1\u201317.", "ArticleIdList": ["9932450"]}, {"Citation": "Arbones M.L., Thomazeau A., Nakano-Kobayashi A., Hagiwara M., Delabar J.M. DYRK1A and cognition: A lifelong relationship. Pharmacol. Ther. 2019;194:199\u2013221. doi: 10.1016/j.pharmthera.2018.09.010.", "ArticleIdList": ["10.1016/j.pharmthera.2018.09.010", "30268771"]}, {"Citation": "Duchon A., Herault Y. DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome. Front. Behav. Neurosci. 2016;10:104. doi: 10.3389/fnbeh.2016.00104.", "ArticleIdList": ["10.3389/fnbeh.2016.00104", "PMC4891327", "27375444"]}, {"Citation": "Tejedor F.J., H\u00e4mmerle B. MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J. 2010;278:223\u2013235. doi: 10.1111/j.1742-4658.2010.07954.x.", "ArticleIdList": ["10.1111/j.1742-4658.2010.07954.x", "21156027"]}, {"Citation": "Thomazeau A., Lassalle O., Lafrati J., Souchet B., Guedj F., Janel N., Chavis P., Delabar J., Manzoni O.J. Prefrontal deficits in a murine model overexpressing the down syndrome candidate gene dyrk1a. J. Neurosci. 2014;34:1138\u20131147. doi: 10.1523/JNEUROSCI.2852-13.2014.", "ArticleIdList": ["10.1523/JNEUROSCI.2852-13.2014", "PMC3953590", "24453307"]}, {"Citation": "De Toma I., Ortega M., Aloy P., Sabid\u00f3 E., Dierssen M. DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment. Front. Mol. Neurosci. 2019;12:272. doi: 10.3389/fnmol.2019.00272.", "ArticleIdList": ["10.3389/fnmol.2019.00272", "PMC6873902", "31803016"]}, {"Citation": "Atas-Ozcan H., Brault V., Duchon A., Herault Y. Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome. Genes. 2021;12:1833. doi: 10.3390/genes12111833.", "ArticleIdList": ["10.3390/genes12111833", "PMC8624927", "34828439"]}, {"Citation": "Mart\u00ednez-Cu\u00e9 C., Rueda N. Signalling Pathways Implicated in Alzheimer\u2019s Disease Neurodegeneration in Individuals with and without Down Syndrome. Int. J. Mol. Sci. 2020;21:6906. doi: 10.3390/ijms21186906.", "ArticleIdList": ["10.3390/ijms21186906", "PMC7555886", "32962300"]}, {"Citation": "Barone E., Arena A., Head E., Butterfield D.A., Perluigi M. Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism. Free Radic. Biol. Med. 2018;114:84\u201393. doi: 10.1016/j.freeradbiomed.2017.07.009.", "ArticleIdList": ["10.1016/j.freeradbiomed.2017.07.009", "PMC5748256", "28705658"]}, {"Citation": "Ermak G., Sojitra S., Yin F., Cadenas E., Cuervo A.M., Davies K.J. Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells. J. Biol. Chem. 2012;287:14088\u201314098. doi: 10.1074/jbc.M111.305342.", "ArticleIdList": ["10.1074/jbc.M111.305342", "PMC3340208", "22389495"]}, {"Citation": "Valenti D., Manente G.A., Moro L., Marra E., Vacca R.A. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: Involvement of the cAMP/PKA signalling pathway. Biochem. J. 2011;435:679\u2013688. doi: 10.1042/BJ20101908.", "ArticleIdList": ["10.1042/BJ20101908", "21338338"]}, {"Citation": "Valenti D., De Rasmo D., Signorile A., Rossi L., de Bari L., Scala I., Granese B., Papa S., Vacca R.A. Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down\u2019s syndrome. Biochim. Biophys. Acta. 2013;1832:542\u2013552. doi: 10.1016/j.bbadis.2012.12.011.", "ArticleIdList": ["10.1016/j.bbadis.2012.12.011", "23291000"]}, {"Citation": "Valenti D., de Bari L., de Rasmo D., Signorile A., Henrion-Caude A., Contestabile A., Vacca R.A. The polyphenols resveratrol and epigallocatechin-3-gallate restore the severe impairment of mitochondria in hippocampal progenitor cells from a Down syndrome mouse model. Biochim. Biophys. Acta. 2016;1862:1093\u20131104. doi: 10.1016/j.bbadis.2016.03.003.", "ArticleIdList": ["10.1016/j.bbadis.2016.03.003", "26964795"]}, {"Citation": "Wang Y., Li M., Xu X., Song M., Tao H., Bai Y. Green tea epigallocatechin-3-gallate (EGCG) promotes neural progenitor cell proliferation and sonic hedgehog pathway activation during adult hippocampal neurogenesis. Mol. Nutr. Food Res. 2012;56:1292\u20131303. doi: 10.1002/mnfr.201200035.", "ArticleIdList": ["10.1002/mnfr.201200035", "22692966"]}, {"Citation": "Hibaoui Y., Grad I., Letourneau A., Sailani M.R., Dahoun S., Santoni F.A., Gimelli S., Guipponi M., Pelte M.F., B\u00e9na F., et al. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol. Med. 2014;6:259\u2013277. doi: 10.1002/emmm.201302848.", "ArticleIdList": ["10.1002/emmm.201302848", "PMC3927959", "24375627"]}, {"Citation": "Gu Y., Moroy G., Paul J.-L., Rebillat A.-S., Dierssen M., De La Torre R., Cieuta-Walti C., Dairou J., Janel N. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup\u00ae Dietary Supplement: Role of Green Tea Catechins. Int. J. Mol. Sci. 2020;21:1404. doi: 10.3390/ijms21041404.", "ArticleIdList": ["10.3390/ijms21041404", "PMC7073110", "32092951"]}, {"Citation": "De la Torre R., De Sola S., Pons M., Duchon A., de Lagran M.M., Farr\u00e9 M., Fit\u00f3 M., Benejam B., Langohr K., Rodriguez J., et al. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol. Nutr. Food Res. 2014;58:278\u2013288. doi: 10.1002/mnfr.201300325.", "ArticleIdList": ["10.1002/mnfr.201300325", "24039182"]}, {"Citation": "Catuara-Solarz S., Espinosa-Carrasco J., Erb I., Langohr K., Notredame C., Gonzalez J.R., Dierssen M. Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome. Front. Behav. Neurosci. 2015;9:330. doi: 10.3389/fnbeh.2015.00330.", "ArticleIdList": ["10.3389/fnbeh.2015.00330", "PMC4675859", "26696850"]}, {"Citation": "Catuara-Solarz S., Espinosa-Carrasco J., Erb I., Langohr K., Gonzalez J.R., Notredame C., Dierssen M. Combined Treatment with Environmental Enrichment and (-)-Epigallocatechin-3-Gallate Ameliorates Learning Deficits and Hippocampal Alterations in a Mouse Model of Down Syndrome. eNeuro. 2016;3:103\u2013116. doi: 10.1523/ENEURO.0103-16.2016.", "ArticleIdList": ["10.1523/ENEURO.0103-16.2016", "PMC5099603", "27844057"]}, {"Citation": "Stagni F., Giacomini A., Emili M., Trazzi S., Guidi S., Sassi M., Ciani E., Rimondini R., Bartesaghi R. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Neuroscience. 2016;333:277\u2013301. doi: 10.1016/j.neuroscience.2016.07.031.", "ArticleIdList": ["10.1016/j.neuroscience.2016.07.031", "27457036"]}, {"Citation": "De Toma I., Ortega M., Catuara-Solarz S., Sierra C., Sabid\u00f3 E., Dierssen M. Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment. Sci. Rep. 2020;10:1\u201318. doi: 10.1038/s41598-020-72625-z.", "ArticleIdList": ["10.1038/s41598-020-72625-z", "PMC7524756", "32994493"]}, {"Citation": "McElyea S.D., Starbuck J.M., Tumbleson-Brink D.M., Harrington E., Blazek J.D., Ghoneima A., Kula K., Roper R.J. Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome. Hum. Mol. Genet. 2016;25:4856\u20134869.", "ArticleIdList": ["PMC6049609", "28172997"]}, {"Citation": "Jamal R., LaCombe J., Patel R., Blackwell M., Thomas J.R., Sloan K., Wallace J.M., Roper R.J. Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models. PLoS ONE. 2022;17:e0264254. doi: 10.1371/journal.pone.0264254.", "ArticleIdList": ["10.1371/journal.pone.0264254", "PMC8865638", "35196359"]}, {"Citation": "Cu\u00e9 C.M., Dierssen M. Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome. Chang. Brains Appl. Brain Plast. Adv. Recover Hum. Abil. 2020;251:269\u2013302.", "ArticleIdList": ["32057310"]}, {"Citation": "Bain J., McLauchlan H., Elliott M., Cohen P. The specificities of protein kinase inhibitors: An update. Biochem. J. 2003;371:199\u2013204. doi: 10.1042/bj20021535.", "ArticleIdList": ["10.1042/bj20021535", "PMC1223271", "12534346"]}, {"Citation": "Becker W., Sippl W. Activation, regulation, and inhibition of dyrk1a. FEBS J. 2011;278:246\u2013256. doi: 10.1111/j.1742-4658.2010.07956.x.", "ArticleIdList": ["10.1111/j.1742-4658.2010.07956.x", "21126318"]}, {"Citation": "Guedj F., S\u00e9bri\u00e9 C., Rivals I., Ledru A., Paly E., Bizot J.C., Smith D., Rubin E., Gillet B., Arbones M., et al. Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS ONE. 2009;4:e4606. doi: 10.1371/journal.pone.0004606.", "ArticleIdList": ["10.1371/journal.pone.0004606", "PMC2645681", "19242551"]}, {"Citation": "Souchet B., Guedj F., Penke-Verdier Z., Daubigney F., Duchon A., Herault Y., Bizot J.-C., Janel N., Cr\u00e9au N., Delatour B., et al. Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models. Front. Behav. Neurosci. 2015;9:267. doi: 10.3389/fnbeh.2015.00267.", "ArticleIdList": ["10.3389/fnbeh.2015.00267", "PMC4611057", "26539088"]}, {"Citation": "Souchet B., Duchon A., Gu Y., Dairou J., Chevalier C., Daubigney F., Nalesso V., Creau N., Yu Y., Janel N., et al. Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models. Sci. Rep. 2019;9:3914. doi: 10.1038/s41598-019-40328-9.", "ArticleIdList": ["10.1038/s41598-019-40328-9", "PMC6408590", "30850713"]}, {"Citation": "Scala I., Valenti D., Scotto D\u2019Aniello V., Marino M., Riccio M.P., Bravaccio C., Vacca R.A., Strisciuglio P. Epigallocatechin-3-Gallate Plus Omega-3 Restores the Mitochondrial Complex I and F0F1-ATP Synthase Activities in PBMCs of Young Children with Down Syndrome: A Pilot Study of Safety and Efficacy. Antioxidants. 2021;10:469. doi: 10.3390/antiox10030469.", "ArticleIdList": ["10.3390/antiox10030469", "PMC8002266", "33809669"]}, {"Citation": "De la Torre R., de Sola S., Hernandez G., Farr\u00e9 M., Pujol J., Rodriguez J., Espadaler J.M., Langohr K., Cuenca-Royo A., Principe A., et al. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with down\u2019s syndrome (TESDAD): A double-blind randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:801\u2013810. doi: 10.1016/S1474-4422(16)30034-5.", "ArticleIdList": ["10.1016/S1474-4422(16)30034-5", "27302362"]}, {"Citation": "Starbuck J.M., Llambrich S., Gonz\u00e0lez R., Albaig\u00e8s J., Sarl\u00e9 A., Wouters J., Gonz\u00e1lez A., Sevillano X., Sharpe J., De La Torre R., et al. Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome. Sci. Rep. 2021;11:4715. doi: 10.1038/s41598-021-83757-1.", "ArticleIdList": ["10.1038/s41598-021-83757-1", "PMC7907288", "33633179"]}, {"Citation": "Xicota L., Rodriguez J., Langohr K., Fito M., Dierssen M., de la Torre R., TESDAD Study Group Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management. Clin. Nutr. 2020;39:1292\u20131300. doi: 10.1016/j.clnu.2019.05.028.", "ArticleIdList": ["10.1016/j.clnu.2019.05.028", "31229326"]}, {"Citation": "Stringer M., Abeysekera I., Dria K.J., Roper R.J., Goodlett C.R. Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model. Pharmacol.Biochem. Behav. 2015;138:70\u201379. doi: 10.1016/j.pbb.2015.09.002.", "ArticleIdList": ["10.1016/j.pbb.2015.09.002", "26363314"]}, {"Citation": "Stringer M., Abeysekera I., Thomas J., Lacombe J., Stancombe K., Stewart R., Dria K., Wallace J.M., Goodlett C.R., Roper R. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes. Physiol. Behav. 2017;177:230\u2013241. doi: 10.1016/j.physbeh.2017.05.003.", "ArticleIdList": ["10.1016/j.physbeh.2017.05.003", "PMC5525541", "28478033"]}, {"Citation": "Goodlett C.R., Stringer M., LaCombe J., Patel R., Wallace J.M., Roper R.J. Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice. Sci. Rep. 2020;10:10426. doi: 10.1038/s41598-020-67133-z.", "ArticleIdList": ["10.1038/s41598-020-67133-z", "PMC7319987", "32591597"]}, {"Citation": "Yang L., Jin X., Yan J., Jin Y., Yu W., Wu H., Xu S. Prevalence of dementia, cognitive status and associated risk factors among elderly of Zhejiang province, China in 2014. Age Ageing. 2016;45:708\u2013712. doi: 10.1093/ageing/afw088.", "ArticleIdList": ["10.1093/ageing/afw088", "27209328"]}, {"Citation": "Villemagne V.L., Burnham S., Bourgeat P., Brown B., Ellis K.A., Salvado O., Szoeke C., Macaulay S.L., Martins R., Maruff P., et al. Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: A prospective cohort study. Lancet Neurol. 2013;12:357\u2013367. doi: 10.1016/S1474-4422(13)70044-9.", "ArticleIdList": ["10.1016/S1474-4422(13)70044-9", "23477989"]}, {"Citation": "Haass C., Selkoe D.J. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 2007;8:101\u2013112. doi: 10.1038/nrm2101.", "ArticleIdList": ["10.1038/nrm2101", "17245412"]}, {"Citation": "Jouanne M., Rault S., Voisin-Chiret A.S. Tau protein aggregation in Alzheimer\u2019s disease: An attractive target for the development of novel therapeutic agents. Eur. J. Med. Chem. 2017;139:153\u2013167. doi: 10.1016/j.ejmech.2017.07.070.", "ArticleIdList": ["10.1016/j.ejmech.2017.07.070", "28800454"]}, {"Citation": "Paula-Lima A.C., Brito-Moreira J., Ferreira S.T. Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer\u2019s disease. J. Neurochem. 2013;126:191\u2013202. doi: 10.1111/jnc.12304.", "ArticleIdList": ["10.1111/jnc.12304", "23668663"]}, {"Citation": "Reddy P.H., Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease. Trends Mol. Med. 2008;14:45\u201353. doi: 10.1016/j.molmed.2007.12.002.", "ArticleIdList": ["10.1016/j.molmed.2007.12.002", "PMC3107703", "18218341"]}, {"Citation": "Di Domenico F., Cenini G., Sultana R., Perluigi M., Uberti D., Memo M., Butterfield D.A. Glutathionylation of the pro-apoptotic protein p53 in Alzheimer\u2019s disease brain: Implications for AD pathogenesis. Neurochem. Res. 2009;34:727\u2013733. doi: 10.1007/s11064-009-9924-9.", "ArticleIdList": ["10.1007/s11064-009-9924-9", "PMC2810644", "19199029"]}, {"Citation": "Birch A.M., Katsouri L., Sastre M. Modulation of inflammation in transgenic models of Alzheimer\u2019s disease. J. Neuroinflamm. 2014;11:25. doi: 10.1186/1742-2094-11-25.", "ArticleIdList": ["10.1186/1742-2094-11-25", "PMC3922595", "24490742"]}, {"Citation": "Elfawy H.A., Das B. Crosstalk between mitochondrial dysfunction, oxidative stress, and age-related neurodegenerative disease: Etiologies and therapeutic strategies. Life Sci. 2018;218:165\u2013184. doi: 10.1016/j.lfs.2018.12.029.", "ArticleIdList": ["10.1016/j.lfs.2018.12.029", "30578866"]}, {"Citation": "Ma Q.P., Huang C., Cui Q.Y., Yang D.J., Sun K., Chen X., Li X.H. Meta-Analysis of the Association between Tea Intake and the Risk of Cognitive Disorders. PLoS ONE. 2016;11:e0165861. doi: 10.1371/journal.pone.0165861.", "ArticleIdList": ["10.1371/journal.pone.0165861", "PMC5100989", "27824892"]}, {"Citation": "Kimura-Ohba S., Yang Y. Oxidative DNA Damage Mediated by Intranuclear MMP Activity Is Associated with Neuronal Apoptosis in Ischemic Stroke. Oxid. Med. Cell. Longev. 2016;2016:6927328. doi: 10.1155/2016/6927328.", "ArticleIdList": ["10.1155/2016/6927328", "PMC4748094", "26925194"]}, {"Citation": "Shay J., Elbaz H.A., Lee I., Zielske S.P., Malek M.H., H\u00fcttemann M. Molecular mechanisms and therapeutic effects of (\u2212)-epicatechin and other polyphenols in cancer, inflammation, diabetes, and neurodegeneration. Oxid. Med. Cell. Longev. 2015;2015:181260. doi: 10.1155/2015/181260.", "ArticleIdList": ["10.1155/2015/181260", "PMC4477097", "26180580"]}, {"Citation": "Lee Y.J., Choi D.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties. J. Nutr. Biochem. 2013;24:298\u2013310. doi: 10.1016/j.jnutbio.2012.06.011.", "ArticleIdList": ["10.1016/j.jnutbio.2012.06.011", "22959056"]}, {"Citation": "M\u00e9rillon J.-M., Ramawat K.G. Bioactive Molecules in Food. 1st ed. Springer Nature; Cham, Switzerland: 2019. pp. 230\u2013256."}, {"Citation": "Bahia P.K., Rattray M., Williams R.J. Dietary flavonoid (\u2013)-epicatechin stimulates phosphatidylinositol 3-kinase-dependent antioxidant response element activity and up-regulates glutathione in cortical astrocytes. J. Neurochem. 2008;106:2194\u20132204.", "ArticleIdList": ["18624917"]}, {"Citation": "Levites Y., Amit T., Youdim M.B., Mandel S. Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 2002;277:30574\u201330580. doi: 10.1074/jbc.M202832200.", "ArticleIdList": ["10.1074/jbc.M202832200", "12058035"]}, {"Citation": "Zhao X., Liu F., Jin H., Li R., Wang Y., Zhang W., Wang H., Chen W. Involvement of PKC\u03b1 and ERK1/2 signaling pathways in EGCG\u2019s protection against stress-induced neural injuries in Wistar rats. Neuroscience. 2017;346:226\u2013237. doi: 10.1016/j.neuroscience.2017.01.025.", "ArticleIdList": ["10.1016/j.neuroscience.2017.01.025", "PMC5421386", "28131624"]}, {"Citation": "Gu H.-F., Nie Y.-X., Tong Q.-Z., Tang Y.-L., Zeng Y., Jing K.-Q., Zheng X.-L., Liao D.-F. Epigallocatechin-3-Gallate Attenuates Impairment of Learning and Memory in Chronic Unpredictable Mild Stress-Treated Rats by Restoring Hippocampal Autophagic Flux. PLoS ONE. 2014;9:e112683. doi: 10.1371/journal.pone.0112683.", "ArticleIdList": ["10.1371/journal.pone.0112683", "PMC4231069", "25393306"]}, {"Citation": "Unno K., Takabayashi F., Yoshida H., Choba D., Fukutomi R., Kikunaga N., Kishido T., Oku N., Hoshino M. Daily consumption of green tea catechin delays memory regression in aged mice. Biogerontology. 2007;8:89\u201395. doi: 10.1007/s10522-006-9036-8.", "ArticleIdList": ["10.1007/s10522-006-9036-8", "16957869"]}, {"Citation": "Pervin M., Unno K., Nakagawa A., Takahashi Y., Iguchi K., Yamamoto H., Hoshino M., Hara A., Takagaki A., Nanjo F., et al. Blood brain barrier permeability of (-)-epigallocatechin gallate, its proliferation-enhancing activity of human neuroblastoma SH-SY5Y cells, and its preventive effect on age-related cognitive dysfunction in mice. Biochem. Biophys. Rep. 2017;9:180\u2013186. doi: 10.1016/j.bbrep.2016.12.012.", "ArticleIdList": ["10.1016/j.bbrep.2016.12.012", "PMC5614586", "28956003"]}, {"Citation": "Rossi L., Mazzitelli S., Arciello M., Capo C.R., Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem. Res. 2008;33:2390\u20132400. doi: 10.1007/s11064-008-9696-7.", "ArticleIdList": ["10.1007/s11064-008-9696-7", "18415677"]}, {"Citation": "Li Q., Zhao H.F., Zhang Z.F., Liu Z.G., Pei X.R., Wang J.B., Li Y. Long-term green tea catechin administration prevents spatial learning and memory impairment in senescence-accelerated mouse prone-8 mice by decreasing Abeta1-42 oligomers and upregulating synaptic plasticity-related proteins in the hippocampus. Neuroscience. 2009;163:741\u2013749. doi: 10.1016/j.neuroscience.2009.07.014.", "ArticleIdList": ["10.1016/j.neuroscience.2009.07.014", "19596052"]}, {"Citation": "Xicota L., Rodriguez-Morato J., Dierssen M., de la Torre R. Potential Role of (\u2212)-Epigallocatechin-3-Gallate (EGCG) in the Secondary Prevention of Alzheimer Disease. Curr. Drug Targets. 2017;18:174\u2013195. doi: 10.2174/1389450116666150825113655.", "ArticleIdList": ["10.2174/1389450116666150825113655", "26302801"]}, {"Citation": "He M., Liu M.Y., Wang S., Tang Q.S., Yao W.F., Zhao H.S., Wei M.J. Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs. Zhong Yao Cai. 2012;35:1641\u20131644.", "ArticleIdList": ["23627134"]}, {"Citation": "Walker J.M., Klakotskaia D., Ajit D., Weisman G.A., Wood W.G., Sun G.Y., Serfozo P., Simonyi A., Schachtman T.R. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer\u2019s disease mouse model. J. Alzheimer\u2019s Dis. 2015;44:561\u2013572. doi: 10.3233/JAD-140981.", "ArticleIdList": ["10.3233/JAD-140981", "25318545"]}, {"Citation": "Bao J., Liu W., Zhou H.-Y., Gui Y.-R., Yang Y.-H., Wu M.-J., Xiao Y.-F., Shang J.-T., Long G.-F., Shu X.-J. Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice. Curr. Med. Sci. 2020;40:18\u201327. doi: 10.1007/s11596-020-2142-z.", "ArticleIdList": ["10.1007/s11596-020-2142-z", "32166661"]}, {"Citation": "Rezai-Zadeh K., Arendash G.W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R.D., Tan J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 2008;1214:177\u2013187. doi: 10.1016/j.brainres.2008.02.107.", "ArticleIdList": ["10.1016/j.brainres.2008.02.107", "18457818"]}, {"Citation": "Lee J.W., Lee Y.K., Ban J.O., Ha T.Y., Yun Y.P., Han S.B., Oh K.W., Hong J.T. Green tea (\u2212)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr. 2009;139:1987\u20131993. doi: 10.3945/jn.109.109785.", "ArticleIdList": ["10.3945/jn.109.109785", "19656855"]}, {"Citation": "Giunta B., Hou H., Zhu Y., Salemi J., Ruscin A., Shytle R.D., Tan J. Fish Oil enhances anti-amyloidogenic properties of Green Tea EGCG in Tg2576 mice. Neurosci. Lett. 2010;471:134\u2013138. doi: 10.1016/j.neulet.2010.01.026.", "ArticleIdList": ["10.1016/j.neulet.2010.01.026", "PMC5822725", "20096749"]}, {"Citation": "Levites Y., Amit T., Mandel S., Youdim M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (\u2212)-epigallocatechin-3-gallate. FASEB J. 2003;17:952\u2013954. doi: 10.1096/fj.02-0881fje.", "ArticleIdList": ["10.1096/fj.02-0881fje", "12670874"]}, {"Citation": "Kao Y.-H., Hiipakka R.A., Liao S. Modulation of Endocrine Systems and Food Intake by Green Tea Epigallocatechin Gallate. Endocrinology. 2000;141:980\u2013987. doi: 10.1210/endo.141.3.7368.", "ArticleIdList": ["10.1210/endo.141.3.7368", "10698173"]}, {"Citation": "Bao S., Cao Y., Fan C., Fan Y., Bai S., Teng W., Shan Z. Epigallocatechin gallate improves insulin signaling by decreasing toll-like receptor 4 (TLR4) activity in adipose tissues of high-fat diet rats. Mol. Nutr. Food Res. 2014;58:677\u2013686. doi: 10.1002/mnfr.201300335.", "ArticleIdList": ["10.1002/mnfr.201300335", "24259392"]}, {"Citation": "Cao Y., Bao S., Yang W., Zhang J., Li L., Shan Z., Teng W. Epigallocatechin gallate prevents inflammation by reducing macrophage infiltration and inhibiting tumor necrosis factor-alpha signaling in the pancreas of rats on a high-fat diet. Nutr. Res. 2014;34:1066\u20131074. doi: 10.1016/j.nutres.2014.10.004.", "ArticleIdList": ["10.1016/j.nutres.2014.10.004", "25453543"]}, {"Citation": "Igarashi K., Honma K., Yoshinari O., Nanjo F., Hara Y. Effects of Dietary Catechins on Glucose Tolerance, Blood Pressure and Oxidative Status in Goto-Kakizaki Rats. J. Nutr. Sci. Vitaminol. 2007;53:496\u2013500. doi: 10.3177/jnsv.53.496.", "ArticleIdList": ["10.3177/jnsv.53.496", "18202537"]}, {"Citation": "Chatree S., Sitticharoon C., Maikaew P., Pongwattanapakin K., Keadkraichaiwat I., Churintaraphan M., Sripong C., Sririwichitchai R., Tapechum S. Epigallocatechin Gallate Decreases Plasma Triglyceride, Blood Pressure, and Serum Kisspeptin in Obese Human Subjects. Exp. Biol. Med. 2020;246:163\u2013176. doi: 10.1177/1535370220962708.", "ArticleIdList": ["10.1177/1535370220962708", "PMC7871112", "33045853"]}, {"Citation": "Zhou J., Mao L., Xu P., Wang Y. Effects of (-)-Epigallocatechin Gallate (EGCG) on Energy Expenditure and Microglia-Mediated Hypothalamic Inflammation in Mice Fed a High-Fat Diet. Nutrients. 2018;10:1681. doi: 10.3390/nu10111681.", "ArticleIdList": ["10.3390/nu10111681", "PMC6266769", "30400620"]}, {"Citation": "Gancar M., Kurin E., Bednarikova Z., Marek J., Mucaji P., Nagy M., Gazova Z. Amyloid Aggregation of Insulin: An Interaction Study of Green Tea Constituents. Sci. Rep. 2020;10:9115. doi: 10.1038/s41598-020-66033-6.", "ArticleIdList": ["10.1038/s41598-020-66033-6", "PMC7272432", "32499589"]}, {"Citation": "Xiong R., Wang X.-L., Wu J.-M., Tang Y., Qiu W.-Q., Shen X., Teng J.-F., Pan R., Zhao Y., Yu L., et al. Polyphenols Isolated from Lychee Seed Inhibit Alzheimer\u2019s Disease-Associated Tau through Improving Insulin Resistance via the IRS-1/PI3K/Akt/GSK-3\u03b2 Pathway. J. Ethnopharmacol. 2020;251:112548. doi: 10.1016/j.jep.2020.112548.", "ArticleIdList": ["10.1016/j.jep.2020.112548", "31917277"]}, {"Citation": "Othman A.I., El-Sawi M.R., El-Missiry M.A., Abukhalil M.H. Epigallocatechin-3-Gallate Protects against Diabetic Cardiomyopathy through Modulating the Cardiometabolic Risk Factors, Oxidative Stress, Inflammation, Cell Death and Fibrosis in Streptozotocin-Nicotinamide-Induced Diabetic Rats. Biomed. Pharmacother. 2017;94:362\u2013373. doi: 10.1016/j.biopha.2017.07.129.", "ArticleIdList": ["10.1016/j.biopha.2017.07.129", "28772214"]}, {"Citation": "Khanra R., Dewanjee S., Dua T.K., Sahu R., Gangopadhyay M., Feo V.D., Zia-Ul-Haq M., Abroma Augusta L. (Malvaceae) Leaf Extract Attenuates Diabetes Induced Nephropathy and Cardiomyopathy via Inhibition of Oxidative Stress and Inflammatory Response. J. Transl. Med. 2015;13:6. doi: 10.1186/s12967-014-0364-1.", "ArticleIdList": ["10.1186/s12967-014-0364-1", "PMC4301895", "25591455"]}, {"Citation": "Chen Y., Hua Y., Li X., Arslan I.M., Zhang W., Meng G. Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy. Front. Pharmacol. 2020;11:42. doi: 10.3389/fphar.2020.00042.", "ArticleIdList": ["10.3389/fphar.2020.00042", "PMC7018666", "32116717"]}, {"Citation": "Ochoa C.D., Wu R.F., Terada L.S. ROS Signaling and ER Stress in Cardiovascular Disease. Mol. Aspects Med. 2018;63:18\u201329. doi: 10.1016/j.mam.2018.03.002.", "ArticleIdList": ["10.1016/j.mam.2018.03.002", "PMC6139279", "29559224"]}, {"Citation": "Yuan M., Gong M., Zhang Z., Meng L., Tse G., Zhao Y., Bao Q., Zhang Y., Yuan M., Liu X., et al. Hyperglycemia Induces Endoplasmic Reticulum Stress in Atrial Cardiomyocytes, and Mitofusin-2 Downregulation Prevents Mitochondrial Dysfunction and Subsequent Cell Death. Oxid Med. Cell Longev. 2020;2020:6569728. doi: 10.1155/2020/6569728.", "ArticleIdList": ["10.1155/2020/6569728", "PMC7603626", "33149811"]}, {"Citation": "\u00d6zcan U., Cao Q., Yilmaz E., Lee A.-H., Iwakoshi N.N., \u00d6zdelen E., Tuncman G., G\u00f6rg\u00fcn C., Glimcher L.H., Hotamisligil G.S. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes. Science. 2004;306:457\u2013461. doi: 10.1126/science.1103160.", "ArticleIdList": ["10.1126/science.1103160", "15486293"]}, {"Citation": "Kim D., Kwon D., Kim M., Kim H.K., Lee Y.C., Park S.J., Yoo W.H., Chae S., Chung M., Kim H., et al. The Involvement of Endoplasmic Reticulum Stress in Flavonoid-induced Protection on Cardiac Cell Death Caused by Ischaemia/Reperfusion. J. Pharm. Pharmacol. 2010;62:197\u2013204. doi: 10.1211/jpp.62.02.0007.", "ArticleIdList": ["10.1211/jpp.62.02.0007", "20487199"]}, {"Citation": "Zhang Q., Li H., Wang S., Liu M., Feng Y., Wang X. Icariin Protects Rat Cardiac H9c2 Cells from Apoptosis by Inhibiting Endoplasmic Reticulum Stress. Int. J. Mol. Sci. 2013;14:17845\u201317860. doi: 10.3390/ijms140917845.", "ArticleIdList": ["10.3390/ijms140917845", "PMC3794756", "23999590"]}, {"Citation": "Chen Y.-H., Lin H., Wang Q., Hou J.-W., Mao Z.-J., Li Y.-G. Protective Role of Silibinin against Myocardial Ischemia/Reperfusion Injury-Induced Cardiac Dysfunction. Int. J. Biol. Sci. 2020;16:1972\u20131988. doi: 10.7150/ijbs.39259.", "ArticleIdList": ["10.7150/ijbs.39259", "PMC7211181", "32398964"]}, {"Citation": "Zhao R., Xie X., Le K., Li W., Moghadasian M.H., Beta T., Shen G.X. Endoplasmic Reticulum Stress in Diabetic Mouse, or Glycated LDL-Treated Endothelial Cells: Protective Effect of Saskatoon Berry Powder and Cyanidin Glycans. J. Nutritional. Biochem. 2015;26:1248\u20131253. doi: 10.1016/j.jnutbio.2015.05.015.", "ArticleIdList": ["10.1016/j.jnutbio.2015.05.015", "26260864"]}, {"Citation": "Formica J.V., Regelson W. Review of the Biology of Quercetin and Related Bioflavonoids. Food Chem. Toxicol. 1995;33:1061\u20131080. doi: 10.1016/0278-6915(95)00077-1.", "ArticleIdList": ["10.1016/0278-6915(95)00077-1", "8847003"]}, {"Citation": "Hu T., Shi J.-J., Fang J., Wang Q., Chen Y.-B., Zhang S.-J. Quercetin Ameliorates Diabetic Encephalopathy through SIRT1/ER Stress Pathway in Db/Db Mice. Aging Albany NY. 2020;12:7015\u20137029. doi: 10.18632/aging.103059.", "ArticleIdList": ["10.18632/aging.103059", "PMC7202537", "32312941"]}, {"Citation": "Morissette A., Kropp C., Songpadith J.-P., Moreira R.J., Costa J., Marin\u00e9-Casad\u00f3 R., Pilon G., Varin T.V., Dudonn\u00e9 S., Boutekrabt L., et al. Blueberry Proanthocyanidins and Anthocyanins Improve Metabolic Health through a Gut Microbiota-Dependent Mechanism in Diet-Induced Obese Mice. Am. J. Physiol.-Endocrinol. Metab. 2020;318:E965\u2013E980. doi: 10.1152/ajpendo.00560.2019.", "ArticleIdList": ["10.1152/ajpendo.00560.2019", "32228321"]}, {"Citation": "Anh\u00ea F.F., Roy D., Pilon G., Dudonn\u00e9 S., Matamoros S., Varin T.V., Garofalo C., Moine Q., Desjardins Y., Levy E., et al. A Polyphenol-Rich Cranberry Extract Protects from Diet-Induced Obesity, Insulin Resistance, and Intestinal Inflammation in Association with Increased Akkermansia spp. Population in the Gut Microbiota of Mice. Gut. 2015;64:872. doi: 10.1136/gutjnl-2014-307142.", "ArticleIdList": ["10.1136/gutjnl-2014-307142", "25080446"]}, {"Citation": "Jiao X., Wang Y., Lin Y., Lang Y., Li E., Zhang X., Zhang Q., Feng Y., Meng X., Li B. Blueberry Polyphenols Extract as a Potential Prebiotic with Anti-Obesity Effects on C57BL/6 J Mice by Modulating the Gut Microbiota. J. Nutr. Biochem. 2019;64:88\u2013100. doi: 10.1016/j.jnutbio.2018.07.008.", "ArticleIdList": ["10.1016/j.jnutbio.2018.07.008", "30471564"]}, {"Citation": "Chen W., Zhu X., Lu Q., Zhang L., Wang X., Liu R. C-Ring Cleavage Metabolites of Catechin and Epicatechin Enhanced Antioxidant Activities through Intestinal Microbiota. Food Res. Int. Ott. Ont. 2020;135:109271. doi: 10.1016/j.foodres.2020.109271.", "ArticleIdList": ["10.1016/j.foodres.2020.109271", "32527491"]}, {"Citation": "Yang C.S., Zhang J., Zhang L., Huang J., Wang Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol. Nutr. Food Res. 2015;60:160\u2013174. doi: 10.1002/mnfr.201500428.", "ArticleIdList": ["10.1002/mnfr.201500428", "PMC4991829", "26577614"]}, {"Citation": "Zhou J., Farah B.L., Sinha R.A., Wu Y., Singh B.K., Bay B., Yen P.M. Epigallocatechin-3-Gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS ONE. 2014;9:e87161. doi: 10.1371/journal.pone.0087161.", "ArticleIdList": ["10.1371/journal.pone.0087161", "PMC3906112", "24489859"]}, {"Citation": "Rocha A., Bolin A.P., Cardoso C.A., Otton R. Green tea extract activates AMPK and ameliorates white adipose tissue metabolic dysfunction induced by obesity. Eur. J. Nutr. 2015;55:2231\u20132244. doi: 10.1007/s00394-015-1033-8.", "ArticleIdList": ["10.1007/s00394-015-1033-8", "26361764"]}, {"Citation": "Grove K.A., Sae-Tan S., Kennett M.J., Lambert J.D. (\u2212)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity. 2012;20:2311\u20132313. doi: 10.1038/oby.2011.139.", "ArticleIdList": ["10.1038/oby.2011.139", "21633405"]}, {"Citation": "Wang S., Sun Z., Dong S., Liu Y., Liu Y. Molecular interactions between (\u2212)-Epigallocatechin gallate analogs and pancreatic lipase. PLoS ONE. 2014;9:e111143. doi: 10.1371/journal.pone.0111143.", "ArticleIdList": ["10.1371/journal.pone.0111143", "PMC4218840", "25365042"]}, {"Citation": "Li D., Zhang Y., Liu Y., Sun R., Xia M. Purified Anthocyanin Supplementation Reduces Dyslipidemia, Enhances Antioxidant Capacity, and Prevents Insulin Resistance in Diabetic Patients. J. Nutrition. 2015;145:742\u2013748. doi: 10.3945/jn.114.205674.", "ArticleIdList": ["10.3945/jn.114.205674", "25833778"]}, {"Citation": "Hoggard N., Cruickshank M., Moar K.-M., Bestwick C., Holst J.J., Russell W., Horgan G. A Single Supplement of a Standardised Bilberry (Vaccinium myrtillus L.) Extract (36% Wet Weight Anthocyanins) Modifies Glycaemic Response in Individuals with Type 2 Diabetes Controlled by Diet and Lifestyle. J. Nutritional Sci. 2013;2:e22. doi: 10.1017/jns.2013.16.", "ArticleIdList": ["10.1017/jns.2013.16", "PMC4153034", "25191571"]}, {"Citation": "Dong J., Zhang X., Zhang L., Bian H.-X., Xu N., Bao B., Liu J. Quercetin Reduces Obesity-Associated ATM Infiltration, and Inflammation in Mice: A Mechanism Including AMPK\u03b11/SIRT1[S] J. Lipid Res. 2014;55:363\u2013374. doi: 10.1194/jlr.M038786.", "ArticleIdList": ["10.1194/jlr.M038786", "PMC3934722", "24465016"]}, {"Citation": "Song J., Kwon O., Chen S., Daruwala R., Eck P., Park J.B., Levine M. Flavonoid Inhibition of Sodium-Dependent Vitamin C Transporter 1 (SVCT1) and Glucose Transporter Isoform 2 (GLUT2), Intestinal Transporters for Vitamin C and Glucose. J. Biol. Chem. 2002;277:15252\u201315260. doi: 10.1074/jbc.M110496200.", "ArticleIdList": ["10.1074/jbc.M110496200", "11834736"]}, {"Citation": "Youl E., Bardy G., Magous R., Cros G., Sejalon F., Virsolvy A., Richard S., Quignard J., Gross R., Petit P., et al. Quercetin Potentiates Insulin Secretion and Protects INS-1 Pancreatic \u0392-cells against Oxidative Damage via the ERK1/2 Pathway. Brit. J. Pharmacol. 2010;161:799\u2013814. doi: 10.1111/j.1476-5381.2010.00910.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.00910.x", "PMC2992896", "20860660"]}, {"Citation": "Zhang B., Buya M., Qin W., Sun C., Cai H., Xie Q., Xu B., Wu Y. Anthocyanins from Chinese Bayberry Extract Activate Transcription Factor Nrf2 in \u03b2 Cells and Negatively Regulate Oxidative Stress-Induced Autophagy. J. Agr. Food Chem. 2013;61:8765\u20138772. doi: 10.1021/jf4012399.", "ArticleIdList": ["10.1021/jf4012399", "23930663"]}, {"Citation": "Mart\u00edn M.\u00c1., Fern\u00e1ndez-Mill\u00e1n E., Ramos S., Bravo L., Goya L. Cocoa Flavonoid Epicatechin Protects Pancreatic Beta Cell Viability and Function against Oxidative Stress. Mol. Nutr. Food Res. 2014;58:447\u2013456. doi: 10.1002/mnfr.201300291.", "ArticleIdList": ["10.1002/mnfr.201300291", "24115486"]}, {"Citation": "Youdim K.A., Shukitt-Hale B., Joseph J.A. Flavonoids and the Brain: Interactions at the Blood\u2013Brain Barrier and Their Physiological Effects on the Central Nervous System. Free Radical Bio. Med. 2004;37:1683\u20131693. doi: 10.1016/j.freeradbiomed.2004.08.002.", "ArticleIdList": ["10.1016/j.freeradbiomed.2004.08.002", "15528027"]}, {"Citation": "Ibars M., Ardid-Ruiz A., Su\u00e1rez M., Muguerza B., Blad\u00e9 C., Aragon\u00e8s G. Proanthocyanidins Potentiate Hypothalamic Leptin/STAT3 Signalling and Pomc Gene Expression in Rats with Diet-Induced Obesity. Int. J. Obes. 2017;41:129\u2013136. doi: 10.1038/ijo.2016.169.", "ArticleIdList": ["10.1038/ijo.2016.169", "PMC5220160", "27677620"]}, {"Citation": "Mi Y., Qi G., Fan R., Qiao Q., Sun Y., Gao Y., Liu X. EGCG Ameliorates High-fat\u2013 and High-fructose-induced Cognitive Defects by Regulating the IRS/AKT and ERK/CREB/BDNF Signaling Pathways in the CNS. Faseb J. 2017;31:4998\u20135011. doi: 10.1096/fj.201700400RR.", "ArticleIdList": ["10.1096/fj.201700400RR", "28739640"]}, {"Citation": "Li H., Kek H.C., Lim J., Gelling R.W., Han W. Green Tea (-)-Epigallocatechin-3-Gallate Counteracts Daytime Overeating Induced by High-Fat Diet in Mice. Mol. Nutr. Food Res. 2016;60:2565\u20132575. doi: 10.1002/mnfr.201600162.", "ArticleIdList": ["10.1002/mnfr.201600162", "27468160"]}, {"Citation": "Koes D.R., Baumgartner M.P., Camacho C.J. Lessons learned in empirical scoring with smina from the CSAR 2011 benchmarking exercise. J. Chem. Inf. Model. 2013;53:1893\u20131904. doi: 10.1021/ci300604z.", "ArticleIdList": ["10.1021/ci300604z", "PMC3726561", "23379370"]}, {"Citation": "Quiroga R., Villarreal M.A. Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening. PLoS ONE. 2016;11:e0155183. doi: 10.1371/journal.pone.0155183.", "ArticleIdList": ["10.1371/journal.pone.0155183", "PMC4865195", "27171006"]}, {"Citation": "Masaki S., Kii I., Sumida Y., Kato-Sumida T., Ogawa Y., Ito N., Nakamura M., Sonamoto R., Kataoka N., Hosoya T., et al. Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis. Bioorgan. Med. Chem. 2015;23:4434\u20134441. doi: 10.1016/j.bmc.2015.06.018.", "ArticleIdList": ["10.1016/j.bmc.2015.06.018", "26145823"]}, {"Citation": "Shen W., Taylor B., Jin Q., Nguyen-Tran T.V., Meeusen S., Zhnag Y.Q., Kamireddy A., Swafford A., Powers A.F., Walker J., et al. Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation. Nat. Commun. 2015;6:8372. doi: 10.1038/ncomms9372.", "ArticleIdList": ["10.1038/ncomms9372", "PMC4639830", "26496802"]}, {"Citation": "Souchet B., Audrain M., Billard J.M., Dairou J., Fol R., Orefice N.S., Tada S., Gu Y., Dufayet-Chaffaud G., Limanton E., et al. Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice. Acta Neuropathol. Commun. 2019;7:46. doi: 10.1186/s40478-019-0678-6.", "ArticleIdList": ["10.1186/s40478-019-0678-6", "PMC6421685", "30885273"]}, {"Citation": "Liu W., Liu X., Tian L., Gao Y., Liu W., Chen H., Jiang X., Xu Z., Ding H., Zhao Q. Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3beta/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. Eur. J. Med. Chem. 2021;222:113554. doi: 10.1016/j.ejmech.2021.113554.", "ArticleIdList": ["10.1016/j.ejmech.2021.113554", "34098466"]}, {"Citation": "Yates A.A., Erdman J.W., Shao A., Dolan L.C., Griffiths J.C. Bioactive nutrients\u2014Time for tolerable upper intake levels to address safety. Regul. Toxicol. Pharmacol. 2017;84:94\u2013101. doi: 10.1016/j.yrtph.2017.01.002.", "ArticleIdList": ["10.1016/j.yrtph.2017.01.002", "28110066"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "9"}, {"Year": "2022", "Month": "5", "Day": "8"}, {"Year": "2022", "Month": "5", "Day": "10"}, {"Year": "2022", "Month": "5", "Day": "28", "Hour": "1", "Minute": "37"}, {"Year": "2022", "Month": "5", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "5", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["35631180", "PMC9147372", "10.3390/nu14102039", "nu14102039"]}}], "PubmedBookArticle": []}